TADAM: Target aware drug activity model for focused library design

27 Nov 2023

In this scientific poster, Selvita highlights challenges in creating target-specific libraries for disease-related targets, emphasizing the need for accessibility, relevance, diversity, and specific chemical characteristics. The challenges include the scale of large compound databases, slow progress due to a lack of activity data for the target of interest, and limitations in the diversity of known active compounds. The solution presented involves a proprietary deep learning model that predicts compound activity towards any target's pocket. This model facilitates the virtual screening of large compound libraries and provides insights into the essential parts of compounds for predicted activity.

Assay development and screening

Selvita

Selvita provides its clients with effective drug discovery support based on broad capabilities and deep expertise in small molecule drug discovery. The in vitro pharmacology support offering at Selvita covers drug discovery phases from target validation through to preclinical candidate selection. We provide a versatile protein-to-cell approach for the development of pharmacologically active compounds and biologics.

(0)

Links

Tags